May Mailman is credited as an animating force behind a strategy that has intimidated independent institutions and undercut years of medical and scientific research.

The Trump administration is opening a new front in its battle with Harvard University on the issue of patents, marking a new escalation with the elite school that could result in the loss of additional federal funding or intellectual property rights.